176 related articles for article (PubMed ID: 38216149)
21. Developing tolerogenic dendritic cell therapy for rheumatoid arthritis: what can we learn from mouse models?
Stoop JN; Robinson JH; Hilkens CM
Ann Rheum Dis; 2011 Sep; 70(9):1526-33. PubMed ID: 21804099
[TBL] [Abstract][Full Text] [Related]
22. Peptide Immunotherapy for Type 1 Diabetes-Clinical Advances.
Smith EL; Peakman M
Front Immunol; 2018; 9():392. PubMed ID: 29541078
[TBL] [Abstract][Full Text] [Related]
23. Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4
Anderson AE; Swan DJ; Wong OY; Buck M; Eltherington O; Harry RA; Patterson AM; Pratt AG; Reynolds G; Doran JP; Kirby JA; Isaacs JD; Hilkens CM
Clin Exp Immunol; 2017 Jan; 187(1):113-123. PubMed ID: 27667787
[TBL] [Abstract][Full Text] [Related]
24. Tolerance induction by liposomes targeting a single CD8 epitope IGRP
Buckle I; Loaiza Naranjo JD; Bergot AS; Zhang V; Talekar M; Steptoe RJ; Thomas R; Hamilton-Williams EE
Immunol Cell Biol; 2022 Jan; 100(1):33-48. PubMed ID: 34668580
[TBL] [Abstract][Full Text] [Related]
25. Oral toleragens in rheumatoid arthritis.
Choy EH
Curr Opin Investig Drugs; 2000 Sep; 1(1):58-62. PubMed ID: 11249596
[TBL] [Abstract][Full Text] [Related]
26. Antigen-specific immunotherapy: is it a real possibility to combat T-cell-mediated autoimmunity?
Tisch R; McDevitt HO
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):437-8. PubMed ID: 8290544
[No Abstract] [Full Text] [Related]
27. Peptide-directed liposomal delivery improves the therapeutic index of an immunomodulatory cytokine in controlling autoimmune arthritis.
Meka RR; Venkatesha SH; Moudgil KD
J Control Release; 2018 Sep; 286():279-288. PubMed ID: 30081142
[TBL] [Abstract][Full Text] [Related]
28. Preclinical models of arthritis for studying immunotherapy and immune tolerance.
Meehan GR; Thomas R; Al Khabouri S; Wehr P; Hilkens CM; Wraith DC; Sieghart D; Bonelli M; Nagy G; Garside P; Tough DF; Lewis HD; Brewer JM
Ann Rheum Dis; 2021 Oct; 80(10):1268-1277. PubMed ID: 34380700
[TBL] [Abstract][Full Text] [Related]
29. Inducing tissue specific tolerance in autoimmune disease with tolerogenic dendritic cells.
Suwandi JS; Toes RE; Nikolic T; Roep BO
Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S97-103. PubMed ID: 26458178
[TBL] [Abstract][Full Text] [Related]
30. Oral tolerization as a treatment of rheumatoid arthritis.
Trentham DE
Rheum Dis Clin North Am; 1998 Aug; 24(3):525-36. PubMed ID: 9710885
[TBL] [Abstract][Full Text] [Related]
31. [The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences].
Bläss S; Engel JM; Burmester GR
Z Rheumatol; 2001 Feb; 60(1):1-16. PubMed ID: 11263010
[TBL] [Abstract][Full Text] [Related]
32. Antigen-specific tolerance approach for rheumatoid arthritis: Past, present and future.
Page A; Fusil F; Cosset FL
Joint Bone Spine; 2021 Jul; 88(4):105164. PubMed ID: 33618000
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapy of rheumatoid arthritis targeting inflammatory cytokines and autoreactive T cells.
Chen G
Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):27-36. PubMed ID: 20049648
[TBL] [Abstract][Full Text] [Related]
34. Mimicking self-antigens with synthetic peptides in systemic autoimmune rheumatic diseases.
Cai C; La Cava A
Curr Clin Pharmacol; 2009 May; 4(2):142-7. PubMed ID: 19442079
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cells: the driving force behind autoimmunity in rheumatoid arthritis?
Pettit AR; Thomas R
Immunol Cell Biol; 1999 Oct; 77(5):420-7. PubMed ID: 10540208
[TBL] [Abstract][Full Text] [Related]
36. Inclusive multisensory science and immunology books for blind, low-vision and diverse-needs audiences.
Favilla S; Tandori E; Marshall J
Immunol Cell Biol; 2024; 102(5):358-364. PubMed ID: 38700076
[TBL] [Abstract][Full Text] [Related]
37. Dendritic cells and their potential implication in pathology and treatment of rheumatoid arthritis.
Wenink MH; Han W; Toes RE; Radstake TR
Handb Exp Pharmacol; 2009; (188):81-98. PubMed ID: 19031022
[TBL] [Abstract][Full Text] [Related]
38. Targeting of tolerogenic dendritic cells towards heat-shock proteins: a novel therapeutic strategy for autoimmune diseases?
Jansen MAA; Spiering R; Broere F; van Laar JM; Isaacs JD; van Eden W; Hilkens CMU
Immunology; 2018 Jan; 153(1):51-59. PubMed ID: 28804903
[TBL] [Abstract][Full Text] [Related]
39. Immunotherapy in collagen-induced arthritis: past, present, and future.
Wooley PH
Am J Med Sci; 2004 Apr; 327(4):217-26. PubMed ID: 15084918
[TBL] [Abstract][Full Text] [Related]
40. The T cell repertoire against cryptic self determinants and its involvement in autoimmunity and cancer.
Moudgil KD; Sercarz EE
Clin Immunol Immunopathol; 1994 Dec; 73(3):283-9. PubMed ID: 7955556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
